Human Molecular Genetics, 2001, Vol. 10, No. 10 1049-1059
© 2001 Oxford University Press
Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release
Laboratory for CAG Repeat Diseases, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
Expansion of CAG repeats within the coding region of target genes is the cause of several autosomal dominant neurodegenerative diseases including Huntington’s disease (HD). A hallmark of HD is the proteolytic production of N-terminal fragments of huntingtin containing polyglutamine repeats that form ubiquitinated aggregates in the nucleus and cytoplasm of the affected neurons. In this study, we used an ecdysone-inducible stable mouse neuro2a cell line that expresses truncated N-terminal huntingtin (tNhtt) with different polyglutamine length, along with mice transgenic for HD exon 1, to demonstrate that the ubiquitin-proteasome pathway is involved in the pathogenesis of HD. Proteasomal 20S core catalytic component was redistributed to the polyglutamine aggregates in both the cellular and transgenic mouse models. Proteasome inhibitor dramatically increased the rate of aggregate formation caused by tNhtt protein with 60 glutamine (60Q) repeats, but had very little influence on aggregate formation by tNhtt protein with 150Q repeats. Both normal and polyglutamine-expanded tNhtt proteins were degraded by proteasome, but the rate of degradation was inversely proportional to the repeat length. The shift of the proteasomal components from the total cellular environment to the aggregates, as well as the comparatively slower degradation of tNhtt with longer polyglutamine, decreased the proteasome’s availability for degrading other key target proteins, such as p53. This altered proteasomal function was associated with disrupted mitochondrial membrane potential, released cytochrome c from mitochondria into the cytosol and activated caspase-9- and caspase-3-like proteases. These results suggest that the impaired proteasomal function plays an important role in polyglutamine protein-induced cell death.
+ To whom correspondence should be addressed. Tel: +81 48 467 9702; Fax: +81 48 462 4796; Email: nukina@brain.riken.go.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. O. Bauer, H. K. Wong, F. Oyama, A. Goswami, M. Okuno, Y. Kino, H. Miyazaki, and N. Nukina Inhibition of Rho Kinases Enhances the Degradation of Mutant Huntingtin J. Biol. Chem., May 8, 2009; 284(19): 13153 - 13164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Furukawa, K. Kaneko, G. Matsumoto, M. Kurosawa, and N. Nukina Cross-Seeding Fibrillation of Q/N-Rich Proteins Offers New Pathomechanism of Polyglutamine Diseases J. Neurosci., April 22, 2009; 29(16): 5153 - 5162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mishra, S. K. Godavarthi, M. Maheshwari, A. Goswami, and N. R. Jana The Ubiquitin Ligase E6-AP Is Induced and Recruited to Aggresomes in Response to Proteasome Inhibition and May Be Involved in the Ubiquitination of Hsp70-bound Misfolded Proteins J. Biol. Chem., April 17, 2009; 284(16): 10537 - 10545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tokui, H. Adachi, M. Waza, M. Katsuno, M. Minamiyama, H. Doi, K. Tanaka, J. Hamazaki, S. Murata, F. Tanaka, et al. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse Hum. Mol. Genet., March 1, 2009; 18(5): 898 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Garyali, P. Siwach, P. K. Singh, R. Puri, S. Mittal, S. Sengupta, R. Parihar, and S. Ganesh The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system Hum. Mol. Genet., February 15, 2009; 18(4): 688 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tonoki, E. Kuranaga, T. Tomioka, J. Hamazaki, S. Murata, K. Tanaka, and M. Miura Genetic Evidence Linking Age-Dependent Attenuation of the 26S Proteasome with the Aging Process Mol. Cell. Biol., February 15, 2009; 29(4): 1095 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Rousseau, R. Kojima, G. Hoffner, P. Djian, and A. Bertolotti Misfolding of Proteins with a Polyglutamine Expansion Is Facilitated by Proteasomal Chaperones J. Biol. Chem., January 16, 2009; 284(3): 1917 - 1929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. King, C. G. Goemans, F. Hafiz, J. H. M. Prehn, A. Wyttenbach, and A. M. Tolkovsky Cytoplasmic Inclusions of Htt Exon1 Containing an Expanded Polyglutamine Tract Suppress Execution of Apoptosis in Sympathetic Neurons J. Neurosci., December 31, 2008; 28(53): 14401 - 14415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tydlacka, C.-E. Wang, X. Wang, S. Li, and X.-J. Li Differential Activities of the Ubiquitin-Proteasome System in Neurons versus Glia May Account for the Preferential Accumulation of Misfolded Proteins in Neurons J. Neurosci., December 3, 2008; 28(49): 13285 - 13295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Seo, W. Kim, and O. Isacson Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients Hum. Mol. Genet., October 15, 2008; 17(20): 3144 - 3153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Wong, P. O. Bauer, M. Kurosawa, A. Goswami, C. Washizu, Y. Machida, A. Tosaki, M. Yamada, T. Knopfel, T. Nakamura, et al. Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism Hum. Mol. Genet., October 15, 2008; 17(20): 3223 - 3235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Southwell, A. Khoshnan, D. E. Dunn, C. W. Bugg, D. C. Lo, and P. H. Patterson Intrabodies Binding the Proline-Rich Domains of Mutant Huntingtin Increase Its Turnover and Reduce Neurotoxicity J. Neurosci., September 3, 2008; 28(36): 9013 - 9020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mishra, P. Dikshit, S. Purkayastha, J. Sharma, N. Nukina, and N. R. Jana E6-AP Promotes Misfolded Polyglutamine Proteins for Proteasomal Degradation and Suppresses Polyglutamine Protein Aggregation and Toxicity J. Biol. Chem., March 21, 2008; 283(12): 7648 - 7656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Doi, K. Okamura, P. O. Bauer, Y. Furukawa, H. Shimizu, M. Kurosawa, Y. Machida, H. Miyazaki, K. Mitsui, Y. Kuroiwa, et al. RNA-binding Protein TLS Is a Major Nuclear Aggregate-interacting Protein in Huntingtin Exon 1 with Expanded Polyglutamine-expressing Cells J. Biol. Chem., March 7, 2008; 283(10): 6489 - 6500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Filimonenko, S. Stuffers, C. Raiborg, A. Yamamoto, L. Malerod, E. M.C. Fisher, A. Isaacs, A. Brech, H. Stenmark, and A. Simonsen Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease J. Cell Biol., November 5, 2007; 179(3): 485 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Young, L. Gouw, S. Propp, B. L. Sopher, J. Taylor, A. Lin, E. Hermel, A. Logvinova, S. F. Chen, S. Chen, et al. Proteolytic Cleavage of Ataxin-7 by Caspase-7 Modulates Cellular Toxicity and Transcriptional Dysregulation J. Biol. Chem., October 12, 2007; 282(41): 30150 - 30160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-J. Lee, A. Panzera, D. Rogawski, L. E. Greene, and E. Eisenberg Cellular prion protein (PrPC) protects neuronal cells from the effect of huntingtin aggregation J. Cell Sci., August 1, 2007; 120(15): 2663 - 2671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fukui and C. T. Moraes Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates Hum. Mol. Genet., April 1, 2007; 16(7): 783 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang and J. Robbins Heart Failure and Protein Quality Control Circ. Res., December 8, 2006; 99(12): 1315 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Goswami, P. Dikshit, A. Mishra, N. Nukina, and N. R. Jana Expression of Expanded Polyglutamine Proteins Suppresses the Activation of Transcription Factor NF{kappa}B J. Biol. Chem., December 1, 2006; 281(48): 37017 - 37024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. P. Ng, J. Howe Fong, D. Sijin Nin, J. L. Hirpara, N. Asou, C.-S. Chen, S. Pervaiz, and M. Khan Cleavage of misfolded nuclear receptor corepressor confers resistance to unfolded protein response-induced apoptosis. Cancer Res., October 15, 2006; 66(20): 9903 - 9912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Dikshit, M. Chatterjee, A. Goswami, A. Mishra, and N. R. Jana Aspirin Induces Apoptosis through the Inhibition of Proteasome Function J. Biol. Chem., September 29, 2006; 281(39): 29228 - 29235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Braun, H. Zischka, F. Madeo, T. Eisenberg, S. Wissing, S. Buttner, S. M. Engelhardt, D. Buringer, and M. Ueffing Crucial Mitochondrial Impairment upon CDC48 Mutation in Apoptotic Yeast J. Biol. Chem., September 1, 2006; 281(35): 25757 - 25767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Benchoua, Y. Trioulier, D. Zala, M.-C. Gaillard, N. Lefort, N. Dufour, F. Saudou, J.-M. Elalouf, E. Hirsch, P. Hantraye, et al. Involvement of Mitochondrial Complex II Defects in Neuronal Death Produced by N-Terminus Fragment of Mutated Huntingtin Mol. Biol. Cell, April 1, 2006; 17(4): 1652 - 1663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Bodner, T. F. Outeiro, S. Altmann, M. M. Maxwell, S. H. Cho, B. T. Hyman, P. J. McLean, A. B. Young, D. E. Housman, and A. G. Kazantsev From the Cover: Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington's and Parkinson's diseases. PNAS, March 14, 2006; 103(11): 4246 - 4251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yamamoto, M. L. Cremona, and J. E. Rothman Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway J. Cell Biol., February 27, 2006; 172(5): 719 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Bett, G. M. Goellner, B. Woodman, G. Pratt, M. Rechsteiner, and G. P. Bates Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REG{gamma} as a therapeutic target Hum. Mol. Genet., January 1, 2006; 15(1): 33 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Iwata, B. E. Riley, J. A. Johnston, and R. R. Kopito HDAC6 and Microtubules Are Required for Autophagic Degradation of Aggregated Huntingtin J. Biol. Chem., December 2, 2005; 280(48): 40282 - 40292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Valera, M. Diaz-Hernandez, F. HernANdez, Z. Ortega, and J. J. Lucas The Ubiquitin-Proteasome System in Huntington's Disease Neuroscientist, December 1, 2005; 11(6): 583 - 594. [Abstract] [PDF]
|
|
|
|
|
|
V. Menendez-Benito, L. G.G.C. Verhoef, M. G. Masucci, and N. P. Dantuma Endoplasmic reticulum stress compromises the ubiquitin-proteasome system Hum. Mol. Genet., October 1, 2005; 14(19): 2787 - 2799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. S. Berke, Y. Chai, G. L. Marrs, H. Wen, and H. L. Paulson Defining the Role of Ubiquitin-interacting Motifs in the Polyglutamine Disease Protein, Ataxin-3 J. Biol. Chem., September 9, 2005; 280(36): 32026 - 32034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S M Hague, S Klaffke, and O Bandmann Neurodegenerative disorders: Parkinson's disease and Huntington's disease J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1058 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nencioni, L. Wille, G. Dal Bello, D. Boy, G. Cirmena, S. Wesselborg, C. Belka, P. Brossart, F. Patrone, and A. Ballestrero Cooperative Cytotoxicity of Proteasome Inhibitors and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Chemoresistant Bcl-2-Overexpressing Cells Clin. Cancer Res., June 1, 2005; 11(11): 4259 - 4265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nencioni, F. Hua, C. P. Dillon, R. Yokoo, C. Scheiermann, M. H. Cardone, E. Barbieri, I. Rocco, A. Garuti, S. Wesselborg, et al. Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis Blood, April 15, 2005; 105(8): 3255 - 3262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Jana, P. Dikshit, A. Goswami, S. Kotliarova, S. Murata, K. Tanaka, and N. Nukina Co-chaperone CHIP Associates with Expanded Polyglutamine Protein and Promotes Their Degradation by Proteasomes J. Biol. Chem., March 25, 2005; 280(12): 11635 - 11640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Bowman, S.-Y. Yoo, N. P. Dantuma, and H. Y. Zoghbi Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation Hum. Mol. Genet., March 1, 2005; 14(5): 679 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-K. Sang, C. Li, W. Liu, A. Rodriguez, J. M. Abrams, S. L. Zipursky, and G. R. Jackson Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis Hum. Mol. Genet., February 1, 2005; 14(3): 357 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gardian, S. E. Browne, D.-K. Choi, P. Klivenyi, J. Gregorio, J. K. Kubilus, H. Ryu, B. Langley, R. R. Ratan, R. J. Ferrante, et al. Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease J. Biol. Chem., January 7, 2005; 280(1): 556 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Morton, N. I. Wood, M. H. Hastings, C. Hurelbrink, R. A. Barker, and E. S. Maywood Disintegration of the Sleep-Wake Cycle and Circadian Timing in Huntington's Disease J. Neurosci., January 5, 2005; 25(1): 157 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Diaz-Hernandez, F. Moreno-Herrero, P. Gomez-Ramos, M. A. Moran, I. Ferrer, A. M. Baro, J. Avila, F. Hernandez, and J. J. Lucas Biochemical, Ultrastructural, and Reversibility Studies on Huntingtin Filaments Isolated from Mouse and Human Brain J. Neurosci., October 20, 2004; 24(42): 9361 - 9371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Rousseau, B. Dehay, L. Ben-Haiem, Y. Trottier, M. Morange, and A. Bertolotti Targeting expression of expanded polyglutamine proteins to the endoplasmic reticulum or mitochondria prevents their aggregation PNAS, June 29, 2004; 101(26): 9648 - 9653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Patenaude, M. R. V. Murthy, and M.-E. Mirault Mitochondrial Thioredoxin System: EFFECTS OF TrxR2 OVEREXPRESSION ON REDOX BALANCE, CELL GROWTH, AND APOPTOSIS J. Biol. Chem., June 25, 2004; 279(26): 27302 - 27314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Jana, P. Dikshit, A. Goswami, and N. Nukina Inhibition of Proteasomal Function by Curcumin Induces Apoptosis through Mitochondrial Pathway J. Biol. Chem., March 19, 2004; 279(12): 11680 - 11685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Shimoke, H. Amano, S. Kishi, H. Uchida, M. Kudo, and T. Ikeuchi Nerve Growth Factor Attenuates Endoplasmic Reticulum Stress-Mediated Apoptosis via Suppression of Caspase-12 Activity J. Biochem., March 1, 2004; 135(3): 439 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Diaz-Hernandez, F. Hernandez, E. Martin-Aparicio, P. Gomez-Ramos, M. A. Moran, J. G. Castano, I. Ferrer, J. Avila, and J. J. Lucas Neuronal Induction of the Immunoproteasome in Huntington's Disease J. Neurosci., December 17, 2003; 23(37): 11653 - 11661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-H. Qin, Y. Wang, K. B. Kegel, A. Kazantsev, B. L. Apostol, L. M. Thompson, J. Yoder, N. Aronin, and M. DiFiglia Autophagy regulates the processing of amino terminal huntingtin fragments Hum. Mol. Genet., December 15, 2003; 12(24): 3231 - 3244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Iwata, M. Maruyama, T. Akagi, T. Hashikawa, I. Kanazawa, S. Tsuji, and N. Nukina Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies Hum. Mol. Genet., October 16, 2003; 12(20): 2625 - 2635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Oostra and R. Willemsen A fragile balance: FMR1 expression levels Hum. Mol. Genet., October 15, 2003; 12(90002): R249 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kanuka, E. Kuranaga, T. Hiratou, T. Igaki, B. Nelson, H. Okano, and M. Miura Cytosol-endoplasmic reticulum interplay by Sec61{alpha} translocon in polyglutamine-mediated neurotoxicity in Drosophila PNAS, September 30, 2003; 100(20): 11723 - 11728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Mandrusiak, L. K. Beitel, X. Wang, T. C. Scanlon, E. Chevalier-Larsen, D. E. Merry, and M. A. Trifiro Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor Hum. Mol. Genet., July 1, 2003; 12(13): 1497 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. C. Tsai, P. S. Fishman, N. V. Thakor, and G. A. Oyler Parkin Facilitates the Elimination of Expanded Polyglutamine Proteins and Leads to Preservation of Proteasome Function J. Biol. Chem., June 6, 2003; 278(24): 22044 - 22055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Willemsen, M. Hoogeveen-Westerveld, S. Reis, J. Holstege, L.-A. W.F.M. Severijnen, I. M. Nieuwenhuizen, M. Schrier, L. van Unen, F. Tassone, A. T. Hoogeveen, et al. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome Hum. Mol. Genet., May 1, 2003; 12(9): 949 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Adachi, M. Katsuno, M. Minamiyama, C. Sang, G. Pagoulatos, C. Angelidis, M. Kusakabe, A. Yoshiki, Y. Kobayashi, M. Doyu, et al. Heat Shock Protein 70 Chaperone Overexpression Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model by Reducing Nuclear-Localized Mutant Androgen Receptor Protein J. Neurosci., March 15, 2003; 23(6): 2203 - 2211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jiang, F. C. Nucifora Jr, C. A. Ross, and D. B. DeFranco Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein Hum. Mol. Genet., January 1, 2003; 12(1): 1 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.Y. E. Chan, J. M. Warrick, I. Andriola, D. Merry, and N. M. Bonini Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila Hum. Mol. Genet., November 1, 2002; 11(23): 2895 - 2904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mitsui, H. Nakayama, T. Akagi, M. Nekooki, K. Ohtawa, K. Takio, T. Hashikawa, and N. Nukina Purification of Polyglutamine Aggregates and Identification of Elongation Factor-1alpha and Heat Shock Protein 84 as Aggregate-Interacting Proteins J. Neurosci., November 1, 2002; 22(21): 9267 - 9277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G.G.C. Verhoef, K. Lindsten, M. G. Masucci, and N. P. Dantuma Aggregate formation inhibits proteasomal degradation of polyglutamine proteins Hum. Mol. Genet., October 15, 2002; 11(22): 2689 - 2700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Araya, M. Maruyama, A. Inoue, T. Fujita, J. Kawahara, K. Sassa, R. Hayashi, Y. Kawagishi, N. Yamashita, E. Sugiyama, et al. Inhibition of proteasome activity is involved in cobalt-induced apoptosis of human alveolar macrophages Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L849 - L858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Keene, C. M. P. Rodrigues, T. Eich, M. S. Chhabra, C. J. Steer, and W. C. Low Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease PNAS, August 6, 2002; 99(16): 10671 - 10676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Mattson, S. L. Chan, and W. Duan Modification of Brain Aging and Neurodegenerative Disorders by Genes, Diet, and Behavior Physiol Rev, July 1, 2002; 82(3): 637 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nishitoh, A. Matsuzawa, K. Tobiume, K. Saegusa, K. Takeda, K. Inoue, S. Hori, A. Kakizuka, and H. Ichijo ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats Genes & Dev., June 1, 2002; 16(11): 1345 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ravikumar, R. Duden, and D. C. Rubinsztein Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy Hum. Mol. Genet., May 1, 2002; 11(9): 1107 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lindsten, F. M.S. de Vrij, L. G.G.C. Verhoef, D. F. Fischer, F. W. van Leeuwen, E. M. Hol, M. G. Masucci, and N. P. Dantuma Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation J. Cell Biol., April 29, 2002; 157(3): 417 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Davies and D B Ramsden Huntington's disease Mol. Pathol., December 1, 2001; 54(6): 409 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Martin-Aparicio, A. Yamamoto, F. Hernandez, R. Hen, J. Avila, and J. J. Lucas Proteasomal-Dependent Aggregate Reversal and Absence of Cell Death in a Conditional Mouse Model of Huntington's Disease J. Neurosci., November 15, 2001; 21(22): 8772 - 8781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zander, J. Takahashi, K. H. El Hachimi, H. Fujigasaki, V. Albanese, A. S. Lebre, G. Stevanin, C. Duyckaerts, and A. Brice Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3 Hum. Mol. Genet., October 1, 2001; 10(22): 2569 - 2579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Cummings, Y. Sun, P. Opal, B. Antalffy, R. Mestril, H. T. Orr, W. H. Dillmann, and H. Y. Zoghbi Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice Hum. Mol. Genet., July 1, 2001; 10(14): 1511 - 1518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lindsten, F. M.S. de Vrij, L. G.G.C. Verhoef, D. F. Fischer, F. W. van Leeuwen, E. M. Hol, M. G. Masucci, and N. P. Dantuma Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation J. Cell Biol., April 29, 2002; 157(3): 417 - 427. [Abstract] [Full Text] [PDF]
|
|